Home » Authors » Mark Lawson

Mark Lawson

Articles

ARTICLES

Two Peptech Directors, Chairman Resign After Only Three Months

April 17, 2002

Prana Releases Positive News In Phase II of Alzheimer’s Drug

April 17, 2002

Australian Governments Agree On Stems Cells; Senate Must OK

April 10, 2002

Amrad Drugs Dropped By GlaxoSmithKline, DevoCo

April 10, 2002

SYDNEY, Australia - Melbourne-based Amrad Ltd. blamed a general industry shift into late-stage research projects on the decision by GlaxoSmithKline plc and DevoCo Pharmaceuticals Ltd. to separately abandon development work on Amrad compounds. (BioWorld International)

Australian Governments Agree On Stems Cells; Senate Must OK

April 10, 2002

Amrad Drugs Dropped By GlaxoSmithKline, DevoCo

April 10, 2002

SYDNEY, Australia - Melbourne-based Amrad Ltd. blamed a general industry shift into late-stage research projects on the decision by GlaxoSmithKline plc and DevoCo Pharmaceuticals Ltd. to separately abandon development work on Amrad compounds. (BioWorld International)

Amrad’s Stock Falls On Poor Phase II Results For Emfilermin

March 27, 2002

Amrad’s Stock Falls On Poor Phase II Results For Emfilermin

March 27, 2002

SCS Has Exclusive Rights To Embryo Cloning Technology

March 20, 2002

SCS Has Exclusive Rights To Embryo Cloning Technology

March 20, 2002

View All Articles by Mark Lawson

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 22, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 21, 2024.
J&J’s Ottava robotic system approved for US pivotal trial
BioWorld MedTech
Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...
Medtronic receives CE mark for next generation Endoflip system
BioWorld MedTech
Medtronic plc obtained a CE mark for its next generation Endoflip 300 system which measures pressure and dimensions in the esophagus and pylorus, in adults. The...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.